News
China is third country to approve Alzheimer’s drug Leqembi
Eisai and Biogen have a third regulatory approval for their …
19755 items found
News
JPM on tenterhooks over Novartis-Cytokinetics merger rumour
With M&A news coming thick and fast on the first day of the JP Morgan …
R&D
Data-driven disease research harnessing the genome
Ben Hargreaves speaks to the UK Biobank to learn more about their …
News
JPM: GSK announces $1.4bn deal to buy asthma biotech Aiolos
GSK has taken another step towards rebuilding its respiratory …
Views & Analysis
JPM: Four ways FDA is seeking to buoy gene therapy
One month ago, the FDA approved two gene therapies for sickle cell …
News
JPM kicks off with takeovers by J&J, Novartis, and MSD
The slew of news from the JP Morgan Healthcare conference that …
Digital
Cracking the code: Unlocking key opinion leaders in the digital landscape
With new guidance, treatment pathways, and medical advances emerging …
R&D
This week in clinical trials: 2nd-5th January 2024
Despite the multiple challenges that faced clinical trials in 2023, …
News
Florida is first US state cleared to import Canadian drugs
The FDA has approved the first request from a US state to import …
News
Servier will apply ‘digital twin’ tech to Parkinson’s drug
French pharma Servier has enlisted the aid of ‘digital twin’ …
News
Rumour mill says MSD is hunting Harpoon Therapeutics
MSD’s 2023 run of pipeline-building deals looks like it could …
News
Isomorphic signs up Lilly, Novartis for $3bn AI drug hunt
Alphabet’s artificial intelligence start-up Isomorphic Labs has made …
News
UK Chancellor pledges £22bn rise in day-to-day NHS spending
In a historic moment today, Rachel Reeves became the first female UK Chancellor to deliver a Budget statement, which featured a major cash injection into the NHS.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
